Patient P-02565

Synthetic patientMETA-24 · Day 170 · 25–34 · M · baseline S09Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S09
Day 113 DT-01 recommended — Dosing / Timing Recommendation DT-01
Day 114 Patient accepted — Started DT-01 in the companion
Day 119 No meaningful change — Dosing / Timing Recommendation DT-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+17
Nutritional resilience-10
Inflammatory activity+7
Toxicity-6
Treatment adherence+5

What helped?

Dosing / Timing Recommendation DT-01Day 113
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

85 min

improving · +4.6 vs previous 14 d

Sleep duration

Wearable

7.2 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.6/10

stable · -0.0 vs previous 14 d

Steps

Wearable

8,500

improving · +413 vs previous 14 d

GI burden

Companion

21.3/100

stable · -0.3 vs previous 14 d

Adherence

Companion

96.2 %

stable · -3.3 vs previous 14 d

Sleep quality

Wearable

55.9/100

stable · +1.9 vs previous 14 d

Glucose, CGM daily mean

CGM

135 mg/dL

stable · -0.9 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 87 from the failing basin, 4 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.8 next day on high-intake days · n 20

Would not help

DT-01 Dosing / Timing Recommendation
already tried, no meaningful change
Keep ultra-processed low
GI +4.1 next day on high-intake days · n 20

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-5.8supporter · 95%
Ultra-processed food
+4.1detractor · 95%
Caffeine
+1.7no signal · 42%
Insoluble fibre
-1.5no signal · 27%
Alcohol
+0.3no signal · 15%
Histamine load
+0.2no signal · 15%
Simple carbohydrates
-0.2no signal · 15%
Dietary fat load
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↑45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure
MTHFR C677T
Reduced folate turnover

Microbiome

Shannon diversity 4.4 · butyrate capacity 76/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 58 ms
Sleep: 7.1 h
Steps: 8,472
Resting HR: 66 bpm

Daily log: GI score 21, nutritional resilience 65, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02337	37%	S18	DT-01	no change	100
P-02249	35%	S09	DT-01	improved	100
P-02189	38%	S17	—	—	96
P-02640	38%	S03	—	—	96
P-02242	38%	S20	—	—	95
P-02013	38%	S14	BR-03	no change	94
P-02104	40%	S15	—	—	94
P-02450	39%	S12	NP-02	improved	92
P-02277	40%	S05	AD-05	improved	92
P-02304	35%	S15	—	—	92
P-02653	38%	S14	—	—	91
P-02689	36%	S13	—	—	91